(Q43834023)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

main subject

Staphylococcus aureus

1 reference

Enterococcus faecium

1 reference

based on heuristic

inferred from title

Enterococcus faecalis

object named as

Enterococcus faecalis

1 reference

Geoffrey A McKay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sylvain Beaulieu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Francis F Arhin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Adam Belley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ingrid Sarmiento

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

15 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1191-1199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19369269%20AND%20SRC:MED&resulttype=core&format=json

Lack of objectivity in the debate concerning third-generation oral contraceptives and venous thrombosis.

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

The importance of bactericidal drugs: future directions in infectious disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Glycopeptide antibiotics: from conventional molecules to new derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Linezolid: the first oxazolidinone antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Bactericidal activity and resistance development profiling of dalbavancin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126

Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP126